Alnylam Pharmaceuticals, Inc.

DUL.DE·XETRA·Healthcare
Compare
144.90+0.75 (+0.52%)today
As of Nov 5, 9:04 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close144.15
Open144.90
Day range—
52-week range141.35407.50
Off day high0.00%
Off 52-week high−64.44%
Volume333
Avg. volume (3M)57.00
Market cap19.41B
EPS (TTM)17.04
Forward P/E—
P/E ratio (TTM)8.50
Dividend yield—
Beta (5Y)0.44
Shares outstanding133.94M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin52.85%

Against its peers

Compare in full ›
DUL.DE IONS ARWR BBIO ROIV 4591.T
Market cap 19.41B 6.62B 8.41B 15.17B 27.11B 3.39B
P/E (TTM) 8.5 — — — — —
Forward P/E — -34.8 -12.0 -225.0 -27.0 -1.1
Price/book 6.0 15.0 18.1 -5.9 6.4 1.2
Dividend yield — — — — — —
1-year change −36.55% −45.82% +55.68% +24.17% +85.85% −29.21%
Today +0.52% −0.77% −3.41% +5.21% −1.83% −4.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Alnylam Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 6.62B 39.84 −0.77%
Arrowhead Pharmaceuticals, Inc.ARWR · Biotechnology 8.41B 59.55 −3.41%
BridgeBio Pharma, Inc.BBIO · Biotechnology 15.17B 77.89 +5.21%
Roivant Sciences Ltd.ROIV · Biotechnology 27.11B 37.53 −1.83%
Ribomic Inc.4591.T · Biotechnology 3.39B 60.00 −4.76%
Ascentage Pharma Group International6855.HK · Biotechnology 11.30B 30.240 +6.70%
ADARx Pharmaceuticals, Inc.ADRX · Biotechnology 1.62B 14.62 −2.31%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 1.99B 18.82 −0.90%

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Moderna, Inc.MRNA · Cambridge, MAOdds 98.56B 246.86 −4.46%
Biogen Inc.BIIB · Cambridge, MA 37.62B 254.51 +0.02%
Akamai Technologies, Inc.AKAM · Cambridge, MAOdds 11.49B 79.98 −6.92%
GE Vernova Inc.GEV · Cambridge, MA 207.08B 782.39 −6.06%
HubSpot, Inc.HUBS · Cambridge, MA 10.67B 208.36 −3.82%
Nuvalent IncNUVL · Cambridge, MA 9.81B 123.96 0.00%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.49B 45.08 −2.19%
Relay Therapeutics, Inc.RLAY · Cambridge, MA 3.74B 17.08 −5.27%

The stocks whose daily moves over the past year went most closely with Alnylam Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Haleon plcHLN.L · Correlation 0.36 29.78B 338.80 +0.36%

What visitors to Alnylam Pharmaceuticals's page also look at.

Company Mkt cap Price Today
VERTEX PHARMACEUTICALS INC.VX1.DE 123.35B 486.65 +0.72%
QUEST DIAGNOSTICS INC.QDI.DE — 225.80 0.00%
Bio-Techne Corp.TE1.F 9.93B 63.22 −0.97%
ROYALTY PHARMA PLCRPD.MU 34.42B 59.57 0.00%
Beone Medicines Ltd.49BA.F 39.36B 346.00 +3.59%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All DUL.DE news ›

From the 4Search news index, newest first.

In the news

18mentions in 30 days
18with it in the headline
Mixedsentiment

Mentioned with

Alnylam15Alnylam Pharmaceuticals, Inc12Alnylam Pharmaceuticals, Inc.10Eli Lilly and Company9Oppenheimer6Abbott Laboratories5Eli Lilly5Acumen Pharmaceuticals, Inc.4

People in the coverage

Kim Johansen11Kirby Mcinerney11Danessa Lincoln10Sarita Garza10Marketbeat9Michael Walen9

Themes

Alny15Healthcare12Lly9SEC Filings813F702043Q106Rnai6EPS5

Most coverage from

  1. themarketsdaily.com8
  2. seekingalpha.com7
  3. defenseworld.net3

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance